OI Olopade
Impact in
-
- Acute Myeloid Leukemia Research
Papers in
-
- Biochemical and Molecular Research 1
- Co-authors
- Rosemarie Mick (2 shared papers)Ahmad R. Safa (1 shared paper)Curtis B. Thompson (1 shared paper)Wendy Recant (1 shared paper)Moses Adeyanju (1 shared paper)Fitsum Hagos (1 shared paper)H. Ralph Schumacher (1 shared paper)MM Le Beau (1 shared paper)
- Journals
- Cancer Research (3 papers)Blood (1 paper)Journal of Clinical Oncology (1 paper)Journal of Asthma (1 paper)East African Medical Journal (1 paper)
- Partner nations
- United StatesNigeria
In The Last Decade
OI Olopade
9 papers receiving 300 citations
Peers
Comparison fields: 5 of 62
- Hematology 68
- Genetics 42
- Molecular Biology 207
- Oncology 70
- Cancer Research 36
Countries citing papers authored by OI Olopade
This map shows the geographic impact of OI Olopade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by OI Olopade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites OI Olopade more than expected).
Fields of papers citing papers by OI Olopade
This network shows the impact of papers produced by OI Olopade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by OI Olopade. The network helps show where OI Olopade may publish in the future.
Co-authors
The 25 scholars most cited alongside OI Olopade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. | 1997 | 172 |
| 2 | 1992 | 73 | |
| 3 | Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancers. | 1993 | 46 |
| 4 | 2011 | 7 | |
| 5 | 2016 | 2 | |
| 6 | Survivorship patterns of histopathological variants and molecular subtypes of breast cancer in a teaching hospital in Nigeria | 2016 | 1 |
| 7 | 2009 | 1 | |
| 8 | 2010 | 1 | |
| 9 | 2009 | 1 | |
| 10 | 2004 | 1 |
About OI Olopade
OI Olopade is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Physiology and Cancer Research, having authored 10 papers that have together received 305 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (2 papers), Asthma and respiratory diseases (2 papers), Cancer Genomics and Diagnostics (1 paper), Hemoglobinopathies and Related Disorders (1 paper), Biochemical and Molecular Research (1 paper), Cancer, Lipids, and Metabolism (1 paper), Acute Myeloid Leukemia Research (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Hematology (68 citations), Genetics (42 citations), Molecular Biology (207 citations), Oncology (70 citations) and Cancer Research (36 citations). OI Olopade has collaborated with scholars based in United States and Nigeria. Frequent co-authors include Rosemarie Mick, Ahmad R. Safa, Curtis B. Thompson, Wendy Recant, Moses Adeyanju, Fitsum Hagos, H. Ralph Schumacher, MM Le Beau, Maya Thangavelu and JW Vardiman. Their work appears in journals such as Cancer Research, Blood, Journal of Clinical Oncology, Journal of Asthma and East African Medical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.